期刊
SCIENTIFIC REPORTS
卷 5, 期 -, 页码 -出版社
NATURE PORTFOLIO
DOI: 10.1038/srep10558
关键词
-
资金
- Generalitat de Catalunya [VAL-TEC 08-1-0016, ACC10]
- MICINN-MINECO [CTQ2008-06200]
- Union Life Sciences Ltd (London)
- Janus Developments (Barcelona)
- Fundacio Bosch i Gimpera (UB)
- Xarxa de Referencia en Biotecnologia (XRB)
Bacterial resistance to almost all available antibiotics is an important public health issue. A major goal in antimicrobial drug discovery is the generation of new chemicals capable of killing pathogens with high selectivity, particularly multi-drug-resistant ones. Here we report the design, preparation and activity of new compounds based on a tunable, chemically accessible and upscalable lipopeptide scaffold amenable to suitable hit-to-lead development. Such compounds could become therapeutic candidates and future antibiotics available on the market. The compounds are cyclic, contain two D-amino acids for in vivo stability and their structures are reminiscent of other cyclic disulfidecontaining peptides available on the market. The optimized compounds prove to be highly active against clinically relevant Gram-negative and Gram-positive bacteria. In vitro and in vivo tests show the low toxicity of the compounds. Their antimicrobial activity against resistant and multidrugresistant bacteria is at the membrane level, although other targets may also be involved depending on the bacterial strain.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据